Debré P - Search Results

1

Viremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and function.

Curriu M, Fausther-Bovendo H, Pernas M, Massanella M, Carrillo J, Cabrera C, López-Galíndez C, Clotet B, Debré P, Vieillard V, Blanco J. Curriu M, et al. Among authors: debre p. PLoS One. 2012;7(2):e30330. doi: 10.1371/journal.pone.0030330. Epub 2012 Feb 1. PLoS One. 2012. PMID: 22312424 Free PMC article.

2

A vaccine strategy against AIDS: an HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques.

Vieillard V, Le Grand R, Dausset J, Debré P. Vieillard V, et al. Among authors: debre p. Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2100-4. doi: 10.1073/pnas.0711629105. Epub 2008 Jan 30. Proc Natl Acad Sci U S A. 2008. PMID: 18234855 Free PMC article.

3

[Towards a vaccine for HIV infection: role of the gp41 envelope protein].

Debre P, Costagliola D, Legrand R, Vieillard V. Debre P, et al. Bull Acad Natl Med. 2009 Jan;193(1):127-36; discussion 137-8. Bull Acad Natl Med. 2009. PMID: 19718985 French.

4

HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway.

Fausther-Bovendo H, Vieillard V, Sagan S, Bismuth G, Debré P. Fausther-Bovendo H, et al. Among authors: debre p. PLoS Pathog. 2010 Jul 1;6(7):e1000975. doi: 10.1371/journal.ppat.1000975. PLoS Pathog. 2010. PMID: 20617170 Free PMC article.

5

[Towards a vaccine against HIV: antibodies raised by a gp41 peptide neutralize the virus and inhibit pathogenesis].

Vieillard V, Debré P. Vieillard V, et al. Among authors: debre p. Biol Aujourdhui. 2015;209(2):161-6. doi: 10.1051/jbio/2015019. Epub 2015 Oct 29. Biol Aujourdhui. 2015. PMID: 26514385 Review. French.

6

NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand.

Vieillard V, Strominger JL, Debré P. Vieillard V, et al. Among authors: debre p. Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):10981-6. doi: 10.1073/pnas.0504315102. Epub 2005 Jul 26. Proc Natl Acad Sci U S A. 2005. PMID: 16046540 Free PMC article.

7

Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.

Vieillard V, Costagliola D, Simon A, Debré P; French Asymptomatiques à Long Terme (ALT) Study Group. Vieillard V, et al. Among authors: debre p. AIDS. 2006 Sep 11;20(14):1795-804. doi: 10.1097/01.aids.0000244198.65263.17. AIDS. 2006. PMID: 16954720

8

NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.

Fausther-Bovendo H, Wauquier N, Cherfils-Vicini J, Cremer I, Debré P, Vieillard V. Fausther-Bovendo H, et al. Among authors: debre p. AIDS. 2008 Jan 11;22(2):217-26. doi: 10.1097/QAD.0b013e3282f46e7c. AIDS. 2008. PMID: 18097224

9

Specific anti-gp41 antibodies predict HIV-1 disease progression.

Vieillard V, Crouzet J, Boufassa F, Sennepin A, Ho Tsong Fang R, Debré P, Meyer L. Vieillard V, et al. Among authors: debre p. J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):403-5. doi: 10.1097/QAI.0b013e318264b307. J Acquir Immune Defic Syndr. 2012. PMID: 22732471

10

An HIVgp41 vaccine protects CD4 central memory T cells in SHIV-infected macaques.

Vieillard V, Dereuddre-Bosquet N, Mangeot-Méderlé I, Le Grand R, Debré P. Vieillard V, et al. Among authors: debre p. Vaccine. 2012 Nov 6;30(48):6883-91. doi: 10.1016/j.vaccine.2012.09.004. Epub 2012 Sep 16. Vaccine. 2012. PMID: 22989687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

440 results

Search Page

Filters